序号 |
标题 |
次数 |
作者 |
发布时间 |
85141 |
DOTA-sst2-ANT;DOTA偶联受体拮抗剂 |
82 |
wyh |
2024-11-27 |
85142 |
二肽联接的二倍体造影剂配体 ;{HO-GK-(DOTA)2} |
105 |
wyh |
2024-11-27 |
85143 |
DOTA-Cys-ZHER2:342;大环DOTA修饰Z HER2:342-半胱氨酸 |
113 |
wyh |
2024-11-27 |
85144 |
DOTA-[Tyr3]-Octreotide 奥曲肽PET探针前体 |
141 |
zcy |
2024-11-26 |
85145 |
Gd-DOTA-HCBP;用于核磁共振成像(MRI)的多肽探针 |
163 |
zcy |
2024-11-26 |
85146 |
204318-14-9,Edotreotide,奥曲肽的多肽,DOTA大环化合物 |
114 |
zcy |
2024-11-26 |
85147 |
1610950-41-8,DOTA-甲基四嗪 |
126 |
zcy |
2024-11-26 |
85148 |
1189194-65-7,DOTA-CH2-Alkynyl (TFA salt) |
85 |
zcy |
2024-11-26 |
85149 |
177943-89-4,DOTATATE,DOTA-3-酪氨酰基-奥曲肽 |
118 |
zcy |
2024-11-26 |
85150 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2;肽类配体 |
152 |
zcy |
2024-11-26 |
85151 |
DOTA-Octreotide,DOTA-奥曲肽 |
110 |
zcy |
2024-11-26 |
85152 |
DOTA-(酪氨酸3)-奥曲肽,DOTA-[Tyr3]-Octreotide,204318-14-9 |
125 |
zcy |
2024-11-26 |
85153 |
PSMA I&T,2192281-54-0 |
107 |
zcy |
2024-11-26 |
85154 |
DOTA-E[cyclo(RGDfK)2] 螯合物前体多肽 |
95 |
zcy |
2024-11-26 |
85155 |
204318-14-9,DOTA-(酪氨酸3)-奥曲肽 |
84 |
zcy |
2024-11-26 |
85156 |
大环配体奥曲肽,Dotatate,DOTA-奥曲肽 |
142 |
zcy |
2024-11-26 |
85157 |
NOTA-8-AOC-BBN(7-14)NH2 ;1,4,7-三氮杂环壬烷-1,4,7-三乙酸-8-氨基辛酸-铃蟾肽 |
152 |
kx |
2024-11-26 |
85158 |
NOTA-Arg-Gly-Asp , NOTA-RGD ,环状螯合剂NOTA偶联多肽RGD |
169 |
kx |
2024-11-26 |
85159 |
NOTA-糖N-乙酰神经氨酸 ,NOTA-Neu5Ac |
122 |
kx |
2024-11-26 |
85160 |
DOTA-[Tyr3]-Octreotide(CAS:204318-14-9),DOTA-(酪氨酸3)-奥曲肽,依多曲肽 |
158 |
zcy |
2024-11-26 |
85161 |
DOTA-3-酪氨酰基-奥曲肽(DOTA-3-tyrosinyl-octreotide) |
108 |
zcy |
2024-11-26 |
85162 |
NOTA-RGD-GE11 ,异二聚体肽缀合NOTA大环配体 |
146 |
kx |
2024-11-26 |
85163 |
DOTA-3-酪氨酰基-奥曲肽,DOTA-(Tyr3)-Octreotate |
111 |
zcy |
2024-11-26 |
85164 |
NOTA-c[KNGRE]-NH2肽 , NOTA修饰c[KNGRE]-NH2肽 |
176 |
kx |
2024-11-26 |
85165 |
DOTA-Ala-Ala-COOH,DOTA-丙氨酸-丙氨酸-羧酸 |
87 |
zcy |
2024-11-26 |
85166 |
NOTA-RGD-GE11, NOTA-RGD-GE11异源二聚肽 |
84 |
kx |
2024-11-26 |
85167 |
DOTA-p-NH2-Bn-Biotin,180978-54-5,DOTA-生物素-肌氨酸 |
104 |
zcy |
2024-11-26 |
85168 |
NOTA-ALT-836-Fab, NOTA偶联ALT-836的Fab片段 |
135 |
kx |
2024-11-26 |
85169 |
C13-多肽;C13(碳-13)同位素标记的多肽 |
231 |
zcy |
2024-11-26 |
85170 |
DOTATATE,177943-89-4,放射性示踪剂 |
119 |
zcy |
2024-11-26 |
85171 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA)螯合寡核苷酸透明质酸(HA)四糖和六糖缀合物 |
218 |
kx |
2024-11-26 |
85172 |
DOTA-RGD,DOTA-cRGDfK,螯合剂修饰多肽 |
131 |
zcy |
2024-11-26 |
85173 |
NOTA-(FHT)2 , FHT肽序列偶联NOTA双功能螯合剂 |
99 |
kx |
2024-11-26 |
85174 |
DOTATATE;DOTA-octreotide;放射性示踪剂 |
118 |
zcy |
2024-11-26 |
85175 |
1201415-84-0,1180007-00-4,DOTA-Lys-Cys-COOH |
84 |
zcy |
2024-11-26 |
85176 |
619300-53-7,DOTA NOC acetate |
160 |
zcy |
2024-11-26 |
85177 |
1306310-00-8,DOTA-Gly-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 |
98 |
zcy |
2024-11-26 |
85178 |
DOTA-NT , DOTA修饰神经降压素受体(NTRs) |
401 |
kx |
2024-11-26 |
85179 |
大环螯合物479081-06-6,DOTA-(COOt-Bu)3-NHFmoc-Lys |
112 |
zcy |
2024-11-26 |
85180 |
NOTA-Ile-Phe-Leu–Leu-Trp-Gln-Arg ,7聚体肽iflwqr偶联NOTA大环配体 |
139 |
kx |
2024-11-26 |
85181 |
DOTA-YHWYGYTPQNVI 大环化合物-多肽 |
100 |
zcy |
2024-11-26 |
85182 |
NOTA-cys(pHLIP ) , NOTA衍生的pH(低)插入肽(pHLIP) |
305 |
kx |
2024-11-26 |
85183 |
放射显影多肽DOTA-JR-11,CAS:1039726-31-2 |
108 |
zcy |
2024-11-26 |
85184 |
金属螯合剂NOTA偶联PS结合的14聚体肽FNFRLKAGAKIRFG (PSBP-6) |
174 |
kx |
2024-11-26 |
85185 |
DOTA-Gd-peptide 钆修饰多肽 |
110 |
zcy |
2024-11-26 |